plateau on glp-1 Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization How to Break a Weight

Ingredient Quality and Formulation Pharmaceutical-grade vs

Oligodendrocyte death initiates synchronous remyelination to restore cortical myelin patterns in mice

Are GLP-1R agonists the long-sought-after panacea for obesity

Exclusion criteria The presence of serious somatic disorders, substance abuse except for cigarettes and caffeine, and history of high mood (mania or hypomania), mental dysfunction, dementia, acute psychiatric disorders according to the psychiatrist, and medication that causes depression in the patient were excluded from the study

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization